Organization
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
2 abstracts
Abstract
Prostate-specific membrane antigen ligand positron emission tomography (PSMA-PET) disease extent and overall survival (OS) in patients (pts) with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC): An international multicenter retrospective study.Org: University of Duisburg-Essen and German Cancer Consortium (DKTK)–University Hospital Essen, Essen, Germany, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany, Peter MacCallum Cancer Centre, Melbourne, Australia, UCLA Department of Nuclear Medicine, Los Angeles, CA, University of California Los Angeles, Los Angeles, CA,
Abstract
Initial efficacy and safety of RP1 + nivolumab in patients with anti–PD-1–failed melanoma from the ongoing phase 1/2 IGNYTE study.Org: Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, The Clatterbridge Cancer Centre and University of Liverpool, Liverpool, United Kingdom, Intermountain Medical Center, Murray, UT, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA,